QuickView for 1 4- bis( 2-( 3, 5- dichloropyridyloxy)) benzene

1. Primary hepatocytes treated with non-genotoxic carcinogens or non-carcinogens
2. Embryonic stem cells treated with non-genotoxic carcinogens or non-carcinogens
3. Liver of CAR KO and KO with human CAR rescue treated with different ligands
4. Livers exposed to CAR agonist TCPOBOP or PXR agonist pregnenolone 16alpha-carbonitrile
5. Liver from mice treated with PXR or CAR ligands

1. Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyrid…
2. The time point of β-catenin knockout in hepatocytes determines their response to xenobiotic activati…
3. Neonatal activation of the nuclear receptor CAR results in epigenetic memory and permanent change of…
4. Transient disruption of liver gap junctional intercellular communication and induction of apoptosis …
5. Treatment with a constitutive androstane receptor ligand ameliorates the signs of preeclampsia in hi…

There were no clinical trials for 1 4- bis( 2-( 3, 5- dichloropyridyloxy)) benzene